Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis, Structure, and Antitumor Activity of Novel Platinum(II) Complexes Involving Asymmetric Chiral Diamines as Carrier Ligands

  • Published : 1999.12.20
Download PDF
⟨ Previous Next ⟩

Abstract

New platinum(II) complexes with asymmetrically substituted chiral diamine ligands A₂PtX₂, (A₂ = NH₂CH(CH₃)CH₂NH($c-C_5H_9)$ (apcpa), NH₂CH(CH₃)CH₂NH($c-C_6H_11)$ (apcha); X₂ = 2Cl, isopropylidenmalonate (IPM), 1,1'-cyclobutandicarboxylate (CBDCA)) have been synthesized and characterized by means of elemental analyses, infrared and NMR spectroscopies, and X-ray crystallography. The crystal structures of (S-apcha)Pt[CBDCA] ·3H₂O (orthorhombic, P2₁2₁2(No. 18), a = 6.926(3), b = 15.243(3), c = 19.319(4)Å, V = 2039.5(10) ų, Z = 4, R = 0.072) and (S-apcha)Pt[IPM] ·2.5 H₂O (monoclinic, P2/C(No. 13), a = 9.882(1), b =18.502(1), c = 22.056(1)Å, V = 4032.8(5)ų, Z = 8, R=0.093) exhibit that the platinum atoms achieve a typical square planar arrangement with two nitrogen atoms in cis position and with the chiral center retained. The spectroscopic data disclose that these platinum complexes are stable and their molecular structures are retained in aqueous solution. Among these platinum complexes, the asymmetric diamine-Pt(II) complexes with chloride leaving group exhibit high in vivo activity comparable to cisplatin against leukemia L1210 cell line.

Keywords

References

  1. Platinum and Other Metal Coordination Complexes in Cancer Chemotherapy Hacker, M. P.;Roberts, J. D.;Nicolini, M.(Ed.)
  2. Cancer Res. v.45 Egorin, M. J.;Van Echo, D. A.;Olman, E. A.;Whitacre, M. Y.;Forrest, A.;Sinor, J. A.
  3. Biochemical Mechanism of Platinum Antitumor Drugs Uacobs, C.;McBerien, D. C. H.;Slater, T. S.
  4. Inorg. Chem. v.29 Bitha, P.;Morton, G. O.;Dunne, T. S.;Deloss Santos, E. F.;Lin, Y.-i.;Boone, S. R.;Haltiwannger R. C. C.;Pierpont, C. G.
  5. Biol. Proc. Int. Symp. Afcharian, A.;Butour, J. L.;Castan, P.;Wimmer, S.;Lons, M.
  6. Cisplartin: Current Status and New Developments Clare, M. J.;Hydes, P. C.;Hepburn, D. R.;Malerbi, B. W.;Prrestako, A. W.(Ed.);Crooke, S. T.(Ed.);Carter, S. K.(Ed.)
  7. Cancer Res. v.40 Mong, S.;Eubanks, C. H.;Prestakyo, A. W.;Crooke, S. T.
  8. Biochemistry v.23 Blatter, E. E.;Vollano, F.;Krishman, B. S.;Dabrowiak, J. C.
  9. Inorg. Chem. v.34 Giandomenico, C. M.;Abrams, M. J.;Murrer, B. A.;Vollen, J. F.;Rheinheimer, M. I.;Wyer, S. B.;Bossard, G. E.;Higgins, J. D.
  10. J. Inorg. Biochem. v.50 Khokear, A. R.;Deng, Y. J.;Kido, Y. C.;Siddik, Z. H.
  11. J. Med. Chem. v.27 Bradon, R. J.;Darbrowiak, J. C.
  12. Polyhedron v.13 Lee, S. S.;Jun, M. J.;Kim, K. M.;Jung, O. S.;Sohn, Y. S.
  13. Reactivity and Structure Concepts in Organic Chemistry 21: The practice of peptide synthesis Bodanszky, M.;Bodanszky, A.
  14. J. Am. Chem. Soc. v.78 Sheehan, J. C.;Goodman, M.;Hess, G. P.
  15. SHELX-97: Program for Crystal Structure Determination Sheldrick, G. M.
  16. Polyhedron v.14 Lee, Y. A.;Jung, O. S.;Sohn, Y. S.
  17. Polyhedron v.15 Jung, C. S.;Lee, S. S.;Jung, O. S.;Sohn, Y. S.
  18. Polyhedron v.16 Lee, E. J.;Jun, M. J.;Lee, S. S:Sohn, Y. S.
  19. Inorg. Chem. v.36 Talman, E. J.;Brunig, W.;Reedijk, J.;Spek, A. L.;Veldmen, N.
  20. Inorg. Chim. Acta v.256 Kim, K. M.;Lee, S. S.;Jung, O. S.;Jun, M. J.;Sohn, Y. S.
  21. Infrared and Raman Spectra of Inorganic and Coordination Compounds Nakamoto, K.
  22. J. Coord. Chem. v.25 Khokear, A. R.;Deng, Y. J.